Skip to main content

Table 3 Short- and long-term MACEs

From: The diagonal branches and outcomes in patients with anterior ST- elevation myocardial infarction

Variables

Total (n = 392)

Flow of the main diagonal branches of LAD

p Value

loss (TIMI 0–1) (n = 69)

no loss (TIMI2–3) (n = 323)

In-hospital MACEs

19(4.8)

10(14.5)

9(2.8)

0.001

 All-cause mortality, n(%)

19(4.8)

10(14.5)

9(2.8)

0.001

 Cardiac mortality, n(%)

13(3.3)

10(14.5)

3(0.9)

0.001

 TVR, n(%)

0

0

0

/

 Recurrent myocardial infarction, n(%)

0

0

0

/

1-month MACEs

23(5.9)

10(14.5)

13(4)

0.003

 All-cause mortality, n(%)

19(4.8)

10(14.5)

9(2.8)

0.001

 Cardiac mortality, n(%)

13(3.3)

10(14.5)

3(0.9)

0.001

 TVR, n(%)

1(0.3)

0

1(0.3)

1

 Recurrent myocardial infarction, n(%)

3(0.8)

0

3(0.9)

1

18-month MACEs

38(9.7)

12(17.4)

26(8)

0.02

 All-cause mortality, n(%)

24(6.1)

12(17.4)

12(3.7)

0.001

 Cardiac mortality, n(%)

16(4.1)

10(14.5)

6(1.9)

0.001

 TVR, n(%)

3(0.8)

0

3(0.9)

1

 Recurrent myocardial infarction, n(%)

11(2.8)

0

11(3.4)

0.23

18-month MACEs (landmark analysisa)

15(4.1)

2(3.4)

13(4.2)

0.77

 All-cause mortality, n(%)

5(1.4)

2(3.4)

3(0.9)

0.21

 Cardiac mortality, n(%)

3(0.8)

0

3(0.9)

1

 TVR, n(%)

2(0.5)

0

2(0.7)

1

 Recurrent myocardial infarction, n(%)

8(2.2)

0

8(2.6)

0.37

18-month MACEs (landmark analysisb)

19(5.1)

2(3.4)

17(5.4)

0.74

 All-cause mortality, n(%)

5(1.3)

2(3.4)

3(0.9)

0.38

 Cardiac mortality, n(%)

3(0.8)

0

3(0.9)

1

 TVR, n(%)

3(0.8)

0

3(0.9)

1

 Recurrent myocardial infarction, n(%)

11(2.9)

0

11(3.5)

0.23

  1. aanalysis starting from 1 month to 18 months. banalysis starting from the time of discharged the hospital to 18 months. LAD Left anterior descending artery, MACEs Major adverse cardiac events, TVR Target vessel revascularization